Product Recalls in New Jersey

Product recalls affecting New Jersey — including food, drugs, consumer products, medical devices, and vehicles distributed to New Jersey. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,862 recalls have been distributed to New Jersey in the last 12 months.

53,621 total recalls
2,862 in last 12 months

Showing 20612080 of 13,536 recalls

DrugMarch 22, 2023· Direct Rx

Recalled Item: Alprazolam C-IV Recalled by Direct Rx Due to CGMP Deviations: Repackaging...

The Issue: CGMP Deviations: Repackaging firm recalling due to potential product cross...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 22, 2023· Direct Rx

Recalled Item: Alprazolam C-IV Recalled by Direct Rx Due to CGMP Deviations: Repackaging...

The Issue: CGMP Deviations: Repackaging firm recalling due to potential product cross...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 22, 2023· Direct Rx

Recalled Item: Alprazolam C-IV Recalled by Direct Rx Due to CGMP Deviations: Repackaging...

The Issue: CGMP Deviations: Repackaging firm recalling due to potential product cross...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Simvastatin 10 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Ropinirole 2mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Simvastatin 40 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Atorvastatin 10 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Glimepiride 2 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Tadalafil 5 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Atorvastatin 20 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 40mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 5mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Doxazosin 2 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 5mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Aripiprazole 5mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Rosuvastatin 10mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 20, 2023· RemedyRepack Inc.

Recalled Item: Ropinirole 0.5 mg tablets Recalled by RemedyRepack Inc. Due to cGMP Deviations

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 17, 2023· Amerisource Health Services LLC

Recalled Item: Glimepiride Tablets Recalled by Amerisource Health Services LLC Due to CGMP...

The Issue: CGMP Deviations: recalling drug products following an FDA inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 17, 2023· Amerisource Health Services LLC

Recalled Item: Glimepiride Tablets Recalled by Amerisource Health Services LLC Due to CGMP...

The Issue: CGMP Deviations: recalling drug products following an FDA inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 17, 2023· Amerisource Health Services LLC

Recalled Item: Glimepiride Tablets Recalled by Amerisource Health Services LLC Due to CGMP...

The Issue: CGMP Deviations: recalling drug products following an FDA inspection.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund